David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap
SNAP
|
+$362M |
| 2 |
Lockheed Martin
LMT
|
+$361M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$354M |
| 4 |
Fidelity National Information Services
FIS
|
+$354M |
| 5 |
Boston Scientific
BSX
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$559M |
| 2 |
Advanced Micro Devices
AMD
|
+$558M |
| 3 |
Boeing
BA
|
+$530M |
| 4 |
Lowe's Companies
LOW
|
+$525M |
| 5 |
Alibaba
BABA
|
+$420M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.94% |
| 2 | Consumer Discretionary | 10.41% |
| 3 | Healthcare | 9.22% |
| 4 | Communication Services | 7.29% |
| 5 | Financials | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Wave Life Sciences
WVE
$1.03B
| $11.8M | 0.01% |
1,499,259
+792,844
| +112% | +$6.65M |
|
1202
The RealReal
REAL
$1.35B
| $11.8M | 0.01% |
603,782
+584,299
| +2,999% | +$9.01M |
|
1203
Medpace
MEDP
$17.1B
| $11.8M | 0.01% |
84,554
-184,076
| -69% | -$23.2M |
|
|
JKS
1204
CALL
JinkoSolar
JKS
$812M
| $11.8M | 0.01% |
190,100
+160,100
| +534% | +$10.1M |
|
1205
Axogen
AXGN
$2.68B
| $11.8M | 0.01% |
656,746
-99,593
| -13% | -$1.46M |
|
|
PCPC.U
1206
DELISTED
Periphas Capital Partnering Corporation CAPS, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
PCPC.U
| $11.8M | 0.01% |
+450,000
| New | +$11.5M |
|
1207
Envista
NVST
$4.41B
| $11.7M | 0.01% |
347,574
+102,296
| +42% | +$2.97M |
|
1208
PUT
Teva Pharmaceuticals
TEVA
$44.4B
| $11.7M | 0.01% |
1,214,800
-236,900
| -16% | -$2.27M |
|
|
X
1209
CALL
DELISTED
US Steel
X
| $11.7M | 0.01% |
697,000
+142,600
| +26% | +$1.77M |
|
1210
Churchill Downs
CHDN
$6.18B
| $11.7M | 0.01% |
119,722
-19,026
| -14% | -$1.73M |
|
1211
CALL
Prudential Financial
PRU
$41.5B
| $11.6M | 0.01% |
148,300
+2,400
| +2% | +$173K |
|
1212
Quest Diagnostics
DGX
$27B
| $11.6M | 0.01% |
+97,097
| New | +$11.8M |
|
|
RP
1213
DELISTED
RealPage, Inc.
RP
| $11.6M | 0.01% |
132,479
-100,887
| -43% | -$6.61M |
|
1214
Donaldson
DCI
$10.8B
| $11.5M | 0.01% |
206,371
+121,054
| +142% | +$6.39M |
|
1215
Carpenter Technology
CRS
$24.1B
| $11.5M | 0.01% |
395,635
-86,071
| -18% | -$1.99M |
|
|
MDP
1216
DELISTED
Meredith Corporation
MDP
| $11.5M | 0.01% |
599,649
+292,563
| +95% | +$4.75M |
|
|
TPTX
1217
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $11.5M | 0.01% |
+94,301
| New | +$10.3M |
|
|
EA
1218
PUT
DELISTED
Electronic Arts
EA
| $11.5M | 0.01% |
80,000
+31,800
| +66% | +$4.1M |
|
1219
Cooper-Standard Automotive
CPS
$474M
| $11.4M | 0.01% |
330,185
+99,891
| +43% | +$2.78M |
|
1220
Elanco Animal Health
ELAN
$12.5B
| $11.4M | 0.01% |
372,013
-284,487
| -43% | -$8.68M |
|
1221
Stantec
STN
$8.26B
| $11.4M | 0.01% |
350,600
+113,300
| +48% | +$3.48M |
|
1222
Arrow Electronics
ARW
$10.3B
| $11.3M | 0.01% |
116,549
+54,649
| +88% | +$4.84M |
|
1223
J.M. Smucker
SJM
$13.4B
| $11.3M | 0.01% |
98,072
-74,373
| -43% | -$8.64M |
|
1224
Halliburton
HAL
$28.2B
| $11.3M | 0.01% |
599,387
-88,792
| -13% | -$1.38M |
|
|
EA
1225
CALL
DELISTED
Electronic Arts
EA
| $11.3M | 0.01% |
78,800
+17,600
| +29% | +$2.27M |
|
Similar funds
David Shaw's Q4 2020 Portfolio in Review
As of Q4 2020, David Shaw held 4,343 positions worth $112B, up 14% from $97.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $10.3B in Q4 2020, closing 477 positions and reducing 1,508 holdings. Its most notable exit was iShares Gold Trust, an estimated $217M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Snowflake worth $147M.
- David Shaw's largest Q4 2020 buy was Snowflake: 523,721 shares worth $147M.
- David Shaw added most to Snap in Q4 2020, an estimated $362M increase.
- David Shaw's biggest Q4 2020 reduction was Tesla, cutting an estimated $559M.
- David Shaw fully exited iShares Gold Trust in Q4 2020, selling an estimated $217M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q4 2020.
- David Shaw opened 563 new positions and closed 477 in Q4 2020.
- David Shaw's portfolio value rose 14% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.